Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

An Investigational Immuno-therapy Study of Nivolumab, and Nivolumab in Combination With Other Anti-cancer Drugs, in Colon Cancer That Has Come Back or Has Spread (CheckMate142)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02060188
Recruitment Status : Active, not recruiting
First Posted : February 11, 2014
Last Update Posted : December 4, 2018
Sponsor:
Information provided by (Responsible Party):
Bristol-Myers Squibb